USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd.

USPTO PatentsView assignee record - 11 granted patents across 18 technology areas, recorded in grant years 2022–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Henan ranks #24,462 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 18 technology areas.

#24,462
of 49,997 US assignees by volume
Top 19%
by Innovation Score (47.0/100)
5.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24462 · Foreign Corporation #24,462 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 11 grants
  • MID-PACK #24,462/49,997
  • PHOTO-FINISH HB Performance Systems
  • CPC-FOCUS A61K · 18 areas
  • INNOV-PAR 47.0/100
  • CLAIMS-SPARSE 5.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2022–2025 · 4y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: HB Performance Systems Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Henan’s 47.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Henan

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Henan's Innovation Score is 47.0/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Henan?

Each dot is one of Henan’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Henan’s own 5.7 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Henan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 10.910.91111.1 051015202530 Granted patents (volume) Avg claims / patent HB Performance Systems Inc. - 11, 16.27HB Performance Sy…HDS Mercury, Inc. - 11, 19.18HDS MercuryHeat IP Holdco, LLC - 11, 16.45Heat IP HoldcoHeidelbergcement AG - 11, 26.09HeidelbergcementHestia Power Inc. - 11, 15Hestia PowerHH Medical, LLC - 11, 5.45HH MedicalHighspot, Inc. - 11, 20.73HighspotHimolla POLSTERMÖBEL GMBH - 11, 7.18Himolla PolstermÖ…Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. - 11, 5.73Henan Zhongda Hen…
Henan vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Henan's grants concentrate

Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. is a focused PatentsView assignee: 18 CPC subclasses with 45.5% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2022. By volume, Henan sits between HB Performance Systems Inc. and Himolla POLSTERMÖBEL GMBH.

Henan's three-year grant acceleration

Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. shows 9 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Henan's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Henan holds 11 patents at rank #24,439, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Henan

By rank, the assignees closest to #24,439 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Henan's primary technology class.

Henan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2022202320242025 2
USPTO utility patent grants by year · 2022–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.

View data table
Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2022 1 9.1%
2023 4 36.4%
2024 4 36.4%
2025partial year 2 18.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd.'s patent record in context - here's where to go next.

  • Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 45.5% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #24,462 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Henan Zhongda Hengyuan Biotechnology Stock Co., Ltd. against HB Performance Systems Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 47.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.